Tower Research Capital (TRC)’s Alzamend Neuro ALZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.32K | Buy |
+797
| New | +$2.32K | ﹤0.01% | 4667 |
|
|
2025
Q1 | – | Sell |
-43
| Closed | -$450 | – | 5153 |
|
|
2024
Q4 | $450 | Sell |
43
-420
| -91% | -$4.4K | ﹤0.01% | 5267 |
|
|
2024
Q3 | $7.04K | Buy |
463
+405
| +698% | +$6.16K | ﹤0.01% | 4083 |
|
|
2024
Q2 | $2.04K | Buy |
58
+5
| +9% | +$176 | ﹤0.01% | 5061 |
|
|
2024
Q1 | $4.75K | Buy |
53
+16
| +43% | +$1.43K | ﹤0.01% | 4637 |
|
|
2023
Q4 | $2.95K | Buy |
37
+1
| +3% | +$80 | ﹤0.01% | 5147 |
|
|
2023
Q3 | $11.5K | Buy |
36
+23
| +177% | +$7.36K | ﹤0.01% | 3985 |
|
|
2023
Q2 | $8.78K | Sell |
13
-9
| -41% | -$6.08K | ﹤0.01% | 4349 |
|
|
2023
Q1 | $12K | Buy |
22
+9
| +69% | +$4.91K | ﹤0.01% | 4044 |
|
|
2022
Q4 | $10K | Buy |
+13
| New | +$10K | ﹤0.01% | 3946 |
|
|
2022
Q3 | – | Sell |
-11
| Closed | -$13K | – | 6027 |
|
|
2022
Q2 | $13K | Buy |
11
+2
| +22% | +$2.36K | ﹤0.01% | 4192 |
|
|
2022
Q1 | $15K | Buy |
+9
| New | +$15K | ﹤0.01% | 3790 |
|
|
2021
Q4 | – | Sell |
-20
| Closed | -$82K | – | 6105 |
|
|
2021
Q3 | $82K | Buy |
20
+18
| +900% | +$73.8K | ﹤0.01% | 2562 |
|
|
2021
Q2 | $18K | Buy |
+2
| New | +$18K | ﹤0.01% | 3977 |
|